Role of Probiotics in the Treatment and Prevention of Common Gastrointestinal Conditions in Children

키워드

참고문헌 (73)

1. "Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria" (2001)[URL]
2. Hill C, "Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic", Nat Rev Gastroenterol Hepatol, 11, pp.506~514 (2014)
3. Jankiewicz M, "Strain-specificity of probiotics in pediatrics : a rapid review of the clinical evidence", J Pediatr Gastroenterol Nutr, 76, pp.227~231 (2023)
4. Zheng J, "A taxonomic note on the genus Lactobacillus : Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae", Int J Syst Evol Microbiol, 70, pp.2782~2858 (2020)
5. Guarino A, "Acute gastroenteritis in children of the world : what veeds to be done?", J Pediatr Gastroenterol Nutr, 70, pp.694~701 (2020)
6. Szajewska H, "Use of probiotics for the management of acute gastroenteritis in children : an update", J Pediatr Gastroenterol Nutr, 71, pp.261~269 (2020)
7. Guarino A, "European Society for Pediatric Gastroenterology, Hepatology, and Nutrition", European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe : update 2014, 2014, pp.59, 132~152
8. Gwee KA, "Consensus and contentious statements on the use of probiotics in clinical practice : a south east Asian gastro-neuro motility association working team report", J Gastroenterol Hepatol, 33, pp.1707~1716 (2018)
9. Marchand V, "Using probiotics in the paediatric population", Paediatr Child Health, 17, pp.575~576 (2012)
10. Szajewska H, "Use of probiotics for management of acute gastroenteritis : a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics", J Pediatr Gastroenterol Nutr, 58, pp.531~539 (2014)
11. Schnadower D, "Lactobacillus rhamnosus GG versus placebo for acute gastroenteritis in children", N Engl J Med, 379, pp.2002~2014 (2018)
12. Szymański H, "Lack of efficacy of Lactobacillus reuteri DSM 17938 for the treatment of acute gastroenteritis : a randomized controlled trial", Pediatr Infect Dis J, 38, pp.e237~42 (2019)
13. Su GL, "AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders", Gastroenterology, 159, pp.697~705 (2020)
14. Freedman SB, "Multicenter trial of a combination probiotic for children with gastroenteritis", N Engl J Med, 379, pp.2015~2026 (2018)
15. Szajewska H, "Probiotics for the management of pediatric gastrointestinal disorders : position paper of the ESPGHAN special interest group on gut microbiota and modifications", J Pediatr Gastroenterol Nutr, 76, pp.232~247 (2023)
16. Barbut F, "Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France", J Clin Microbiol, 40, pp.2079~2083 (2002)
17. McFarland LV, "Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients", J Infect Dis, 162, pp.678~684 (1990)
18. Szajewska H, "Probiotics for the prevention of antibiotic-associated diarrhea in children", J Pediatr Gastroenterol Nutr, 62, pp.495~506 (2016)
19. Storr M, "Systematic review: clinical evidence of probiotics in the prevention of antibiotic-associated diarrhoea", MMW Fortschr Med, 163(Suppl 4), pp.19~26 (2021)
20. Hyams JS, "Functional Disorders: Children and Adolescents", Gastroenterology (2016)
21. Benninga MA, "Childhood functional gastrointestinal disorders : neonate", toddler, 2016, pp.150, 1443~1455
22. Korterink J, "Childhood functional abdominal pain : mechanisms and management", Nat Rev Gastroenterol Hepatol, 12, pp.159~171 (2015)
23. Hojsak I, "Probiotics in functional gastrointestinal disorders", Adv Exp Med Biol, 1125, pp.121~137 (2019)
24. Sung V, "Lactobacillus reuteri to treat infant colic : a meta-analysis", Pediatrics, 141, pp.e20171811~ (2018)
25. Nocerino R, "The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12® in infant colic : A randomised, double blind, placebo-controlled trial", Aliment Pharmacol Ther, 51, pp.110~120 (2020)
26. Chen K, "Efficacy of Bifidobacterium animalis subsp. lactis, BB-12® on infant colic-a randomised, double-blinded, placebo-controlled study", Benef Microbes, 12, pp.531~540 (2021)
27. Romano C, "Lactobacillus reuteri in children with functional abdominal pain(FAP)", J Paediatr Child Health, 50, pp.E68~71 (2014)
28. Weizman Z, "Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood : a randomized, double-blind, placebo-controlled trial", J Pediatr, 174, pp.160~164 (2016)
29. Jadrešin O, "Lactobacillus reuteri DSM 17938 in the treatment of functional abdominal pain in children : RCT study", J Pediatr Gastroenterol Nutr, 64, pp.925~929 (2017)
30. Maragkoudaki M, "Lactobacillus reuteri DSM 17938 and a placebo both significantly reduced symptoms in children with functional abdominal pain", Acta Paediatr, 106, pp.1857~1862 (2017)
31. Eftekhari K, "A randomized double-blind placebo-controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children", Iran J Pediatr, 25, pp.e2616~ (2015)
32. Trivić I, "Use of probiotics in the treatment of functional abdominal pain in children-systematic review and meta-analysis", Eur J Pediatr, 180, pp.339~351 (2021)
33. Xu HL, "Efficacy of probiotic adjuvant therapy for irritable bowel syndrome in children : a systematic review and meta-analysis", PLoS One, 16, pp.e0255160~ (2021)
34. Koppen IJN, "Prevalence of functional defecation disorders in children : a systematic review and meta-analysis", J Pediatr, 198, pp.121~130 (2018)
35. Benninga MA, "Childhood constipation : is there new light in the tunnel?", J Pediatr Gastroenterol Nutr, 39, pp.448~464 (2004)
36. de Meij TG, "Characterization of microbiota in children with chronic functional constipation", PLoS One, 11, pp.e0164731~ (2016)
37. Tabbers MM, "Evaluation and treatment of functional constipation in infants and children : evidence-based recommendations from ESPGHAN and NASPGHAN", J Pediatr Gastroenterol Nutr, 58, pp.258~274 (2014)
38. Wegh CAM, "Nonpharmacologic treatment for children with functional constipation : a systematic review and meta-analysis", J Pediatr, 240, pp.136~149 (2022)
39. Warren JR, "Unidentified curved bacilli on gastric epithelium in active chronic gastritis", Lancet, 1, pp.1273~1275 (1983)
40. Zamani M, "Systematic review with meta-analysis : the worldwide prevalence of Helicobacter pylori infection", Aliment Pharmacol Ther, 47, pp.868~876 (2018)
41. Jones NL, "joint ESPGHAN", NASPGHAN guidelines for the management of Helicobacter pylori in vhildren and adolescents(update 2016), 2017, pp.64, 991~1003
42. Kato S, "The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood", Pediatr Int, 62, pp.1315~1331 (2020)
43. Graham DY, "Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy : studies from the United States", J Gastroenterol, 45, pp.816~820 (2010)
44. Lai HH, "Treatment of pediatric Helicobacter pylori infection", Antibiotics(Basel), 11, pp.757~ (2022)
45. Pacifico L, "Probiotics for the treatment of Helicobacter pylori infection in children", World J Gastroenterol, 20, pp.673~683 (2014)
46. Lü M, "Efficacy of probiotic supplementation therapy for Helicobacter pylori eradication : a meta-analysis of randomized controlled trials", PLoS One, 11, pp.e0163743~ (2016)
47. Feng JR, "Efficacy and safety of probiotic-supplemented triple therapy for eradication of Helicobacter pylori in children : a systematic review and network meta-analysis", Eur J Clin Pharmacol, 73, pp.1199~1208 (2017)
48. Zhou BG, "Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication : a systematic review and meta-analysis with trial sequential analysis", Helicobacter, 24, pp.e12651~ (2019)
49. Fang HR, "Efficacy of Lactobacillus-supplemented triple therapy for Helicobacter pylori infection in children : a meta-analysis of randomized controlled trials", Eur J Pediatr, 178, pp.7~16 (2019)
50. Grumet L, "The development of high-quality multispecies probiotic formulations : from bench to market", Nutrients, 12, pp.2453~ (2020)
51. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), "Guidance on the characterisation of microorganisms used as feed additives or as production organisms", EFSA J, 16, pp.e05206~ (2018)
52. "Updated list of QPS-recommended microorganisms for safety risk assessments carried out by EFSA" (2023)[URL]
53. "Generally Recognized as Safe (GRAS)"[URL]
54. Hempel S, "Safety of probiotics used to reduce risk and prevent or treat disease", Evid Rep Technol Assess(Full Rep), (200), pp.1~645 (2011)
55. Wallace C, "Probiotics for management of functional abdominal pain disorders in children", Cochrane Database Syst Rev, 2, pp.CD012849~ (2023)
56. Bafeta A, "Harms reporting in randomized controlled trials of interventions aimed at modifying microbiota : a systematic review", Ann Intern Med, 169, pp.240~247 (2018)
57. Costa RL, "Infectious complications following probiotic ingestion: a potentially underestimated problem? a systematic review of reports and case series", BMC Complement Altern Med, 18, pp.329~ (2018)
58. D’Agostin M, "Invasive infections associated with the use of probiotics in children : a systematic review", Children(Basel), 8, pp.924~ (2021)
59. Barton LL, "Bacteremic infection with Pediococcus : vancomycin-resistant opportunist", Pediatrics, 107, pp.775~776 (2001)
60. Brecht M, "Lactobacillus sepsis following a laparotomy in a preterm infant : a note of caution", Neonatology, 109, pp.186~189 (2016)
61. Vallabhaneni S, "Notes from the field : Fatal gastrointestinal mucormycosis in a premature infant associated with a contaminated dietary supplement--Connecticut, 2014", MMWR Morb Mortal Wkly Rep, 64, pp.155~156 (2015)
62. Grześkowiak Ł, "Manufacturing process influences properties of probiotic bacteria", Br J Nutr, 105, pp.887~894 (2011)
63. Duboux S, "The possible link between manufacturing and probiotic efficacy; a molecular point of view on Bifidobacterium", Front Microbiol, 12, pp.812536~ (2021)
64. Fenster K, "The production and delivery of probiotics : a review of a practical approach", Microorganisms, 7, pp.83~ (2019)
65. Jackson SA, "Improving end-user trust in the quality of commercial probiotic products", Front Microbiol, 10, pp.739~ (2019)
66. Sanders ME, "Bringing a probiotic-containing functional food to the market : microbiological, product, regulatory and labeling issues", Antonie Van Leeuwenhoek, 76, pp.293~315 (1999)
67. "Public consultation on the EFSA statement on the requirements for whole genome sequence analysis of microorganisms intentionally used in the food chain" (2020)[URL]
69. Kolaček S, "Commercial probiotic products : a call for improved quality control. A position paper by the ESPGHAN working group for probiotics and prebiotics", J Pediatr Gastroenterol Nutr, 65, pp.117~124 (2017)
70. Wang Y, "Whole-genome analysis of probiotic product isolates reveals the presence of genes related to antimicrobial resistance, virulence factors, and toxic metabolites, posing potential health risks", BMC Genomics, 22, pp.210~ (2021)
71. Vecchione A, "Compositional quality and potential gastrointestinal behavior of probiotic products commercialized in Italy", Front Med(Lausanne), 5, pp.59~ (2018)
72. Vermeulen MJ, "Quality of probiotic products for preterm infants : Contamination and missing strains", Acta Paediatr, 109, pp.276~279 (2020)
73. Dioso CM, "Do your kids get what you paid for? Evaluation of commercially available probiotic products intended for children in the republic of the philippines and the republic of Korea", Foods, 9, pp.1229~ (2020)

관련 논문AI추천